Raymond James & Associates’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-12,070
| Closed | -$1.83M | – | 3976 |
|
|
2022
Q3 | $1.83M | Sell |
12,070
-24,559
| -67% | -$3.71M | ﹤0.01% | 2029 |
|
|
2022
Q2 | $5.34M | Sell |
36,629
-2,238
| -6% | -$326K | 0.01% | 1362 |
|
|
2022
Q1 | $4.61M | Buy |
38,867
+2,167
| +6% | +$257K | ﹤0.01% | 1564 |
|
|
2021
Q4 | $5.06M | Buy |
36,700
+16,995
| +86% | +$2.34M | ﹤0.01% | 1544 |
|
|
2021
Q3 | $2.74M | Sell |
19,705
-112
| -0.6% | -$15.6K | ﹤0.01% | 1879 |
|
|
2021
Q2 | $1.92M | Buy |
19,817
+1,158
| +6% | +$112K | ﹤0.01% | 2125 |
|
|
2021
Q1 | $1.28M | Buy |
18,659
+6,907
| +59% | +$472K | ﹤0.01% | 2331 |
|
|
2020
Q4 | $1.01M | Sell |
11,752
-364
| -3% | -$31.2K | ﹤0.01% | 2334 |
|
|
2020
Q3 | $788K | Buy |
12,116
+884
| +8% | +$57.5K | ﹤0.01% | 2313 |
|
|
2020
Q2 | $821K | Sell |
11,232
-77
| -0.7% | -$5.63K | ﹤0.01% | 2281 |
|
|
2020
Q1 | $385K | Buy |
11,309
+1,918
| +20% | +$65.3K | ﹤0.01% | 2596 |
|
|
2019
Q4 | $511K | Sell |
9,391
-4,273
| -31% | -$233K | ﹤0.01% | 2711 |
|
|
2019
Q3 | $570K | Sell |
13,664
-199
| -1% | -$8.3K | ﹤0.01% | 2554 |
|
|
2019
Q2 | $607K | Sell |
13,863
-3,396
| -20% | -$149K | ﹤0.01% | 2526 |
|
|
2019
Q1 | $888K | Buy |
17,259
+148
| +0.9% | +$7.62K | ﹤0.01% | 2272 |
|
|
2018
Q4 | $633K | Sell |
17,111
-239
| -1% | -$8.84K | ﹤0.01% | 2384 |
|
|
2018
Q3 | $651K | Sell |
17,350
-222
| -1% | -$8.33K | ﹤0.01% | 2521 |
|
|
2018
Q2 | $694K | Sell |
17,572
-32
| -0.2% | -$1.26K | ﹤0.01% | 2451 |
|
|
2018
Q1 | $453K | Buy |
17,604
+1,095
| +7% | +$28.2K | ﹤0.01% | 2619 |
|
|
2017
Q4 | $445K | Buy |
16,509
+758
| +5% | +$20.4K | ﹤0.01% | 2594 |
|
|
2017
Q3 | $589K | Buy |
15,751
+41
| +0.3% | +$1.53K | ﹤0.01% | 2381 |
|
|
2017
Q2 | $393K | Buy |
+15,710
| New | +$393K | ﹤0.01% | 2548 |
|